Seroquel XR For Depression? Two Recent Studies Weigh In
The Carlat Psychiatry Report, Volume 7, Number 6, June 2009
https://www.thecarlatreport.com/newsletter-issue/tcprv7n6/
Issue Links: Learning Objectives | Editorial Information
Topics: Antidepressants
Section editor, Glen Spielmans, PhD
Suddenly, psychopharmacology has apparently become “all Seroquel, all the time.” AstraZeneca’s atypical antipsychotic (generic name, extended release quetiapine), which already had FDA approval for schizophrenia and bipolar mania, recently won approval for bipolar depression, and is now pushing for indications in depression and generalized anxiety disorder (GAD).
You can't view details of this content, please login or buy subscription here
Section editor, Glen Spielmans, PhD
Glen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies ertaining to this educational activity.